Article

The Establishment of Prostate-specific, SKP2 Humanized Mice by CRISPR Knock-in Method Reveals Neoplastic Initiation and Microenvironmental Reprogramming

2026-01-07

Abstract excerpt

<title>Abstract</title> <p>Genetic inactivation of SKP2 has been shown to effectively prevent cancer initiation and block tumorigenesis. However, direct in vivo evidence for SKP2 on cancer initiation and prostatic microenvironment is still lacking and a SKP2 humanized mouse model is critical for developing prostate cancer immunoprevention approaches through targeting SKP2. We therefore have established a prostate...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 7514bbdc-1aa0-570a-935f-ea1150605023
DOI: 10.21203/rs.3.rs-8384571/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The Establishment of Prostate-specific, SKP2 Humanized Mice by CRISPR Knock-in Method Reveals Neoplastic Initiation and Microenvironmental ReprogrammingDOI 10.21203/rs.3.rs-8384571/v1Read

The Establishment of Prostate-specific, SKP2 Humanized Mice by CRISPR Knock-in Method Reveals Neoplastic Initiation and Microenvironmental ReprogrammingSemantic proximity Read

High Skp2 expression is associated with a mesenchymal phenotype and increased tumorigenic potential of prostate cancer cellsSemantic proximity Read

ProMPt: A modular preclinical platform for functional modelling of prostate cancer heterogeneity and therapeutic vulnerabilitiesSemantic proximity Read

Biobank of genetically defined murine prostate cancer tumoroids uncovers oncogenic pathways and drug vulnerabilities driven by PTEN-lossSemantic proximity Read

CRISPR/Cas9 model of prostate cancer identifies Kmt2c deficiency as a metastatic driver by Odam/Cabs1 gene cluster expressionSemantic proximity Read

Human iPSC-derived prostate organoids with germline BRCA2 mutation undergo tumorigenic transformationsSemantic proximity Read

Targeting Chromatin Effector Pygo2 to Enhance Immunotherapy in Prostate CancerSemantic proximity Read

<em>In Vivo </em>Models for Prostate Cancer ResearchSemantic proximity Read

Patient-derived prostate cancer organoids require α6-integrins for self-renewal and recapitulate genetic heterogeneity and histopathology of the original tumorsSemantic proximity Read

The neuroendocrine transition in prostate cancer is dynamic and dependent on ASCL1Semantic proximity Read

CRISPR/Cas9 model of prostate cancer identifies Kmt2c deficiency as a metastatic driver by Odam/Cabs1 gene cluster expressionSemantic proximity Read

Pre-Clinical Models to Study Human Prostate CancerSemantic proximity Read